相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARγ cross talk with NF-κB and C/EBPβ
Li Hua Wang et al.
BLOOD (2007)
Telmisartan, an angiotensin II type 1 receptor blocker, controls progress of nonalcoholic steatohepatitis in rats
Koji Fujita et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-κB and C/EBP β activation
Devang N. Patel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Increased expression of CCAAT/enhancer binding protein-β and -δ and monocyte chemoattractant protein-1 genes in aortas from hyperinsulinaemic rats
Y. Sato et al.
DIABETOLOGIA (2007)
Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets
Jonathan D. Brown et al.
CIRCULATION (2007)
Biomarkers of atherosclerotic plaque instability and rupture
Wolfgang Koenig et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Telmisartan inhibits β2-integrin MAC-1 expression in human T-lymphocytes
Andreas Link et al.
JOURNAL OF HYPERTENSION (2006)
Is there more than C-reactive protein and fibrinogen? The prognostic value of soluble CD40 ligand, interleukin-6 and oxidized low-density lipoprotein with respect to coronary and cerebral vascular disease
M. B. I. Lobbes et al.
ATHEROSCLEROSIS (2006)
Role of angiotensin II in cardiovascular disease - Therapeutic implications of more than a century of research
CM Ferrario
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2006)
Combinatorial roles of nuclear receptors in inflammation and immunity
CK Glass et al.
NATURE REVIEWS IMMUNOLOGY (2006)
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
G Pascual et al.
NATURE (2005)
The impart of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes
EL Gillespie et al.
DIABETES CARE (2005)
Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers - A meta-analysis
JS Healey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Nuclear factor κB signaling in atherogenesis
MPJ de Winther et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Drug therapy: Thiazolidinediones
H Yki-Jarvinen
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy
AH Barnett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells
S Watanabe et al.
AMERICAN JOURNAL OF NEPHROLOGY (2004)
Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-α activity
M Schupp et al.
CIRCULATION (2004)
Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity
SC Benson et al.
HYPERTENSION (2004)
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
MA Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes
JW Phillips et al.
CIRCULATION (2003)
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors:: the CHARM-Added trial
JJV McMurray et al.
LANCET (2003)
Troglitazone antagonizes tumor necrosis factor-α-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-κB
H Ruan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-δ and peroxisome proliferator-activated receptor-γ
Y Takata et al.
CIRCULATION RESEARCH (2002)
NF-κB is required for TNF-α-directed smooth muscle cell migration
ZB Wang et al.
FEBS LETTERS (2001)
Peroxisome proliferator-activate inhibit development of atherosclerosis in LDL receptor-deficient mice
AC Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients
J Stangier et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2000)
分享论文
